Werewolf Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Werewolf Therapeutics, Inc. announces its 2025 Annual Meeting of Shareholders to be held on June 12, 2025, featuring proposals including the election of directors and ratification of the company's accounting firm.
NASDAQ
Werewolf Therapeutics announces its 2025 annual meeting of stockholders to be held virtually on June 12, 2025, to elect directors and ratify the appointment of Ernst & Young LLP as its independent auditor.
NASDAQ
Werewolf Therapeutics, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Werewolf Therapeutics announces its 2024 annual meeting of stockholders to be held virtually on May 24, 2024, focusing on director elections and auditor ratification.